Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAd regimen in relapsed and refractory multiple myeloma
NCT05006469Phase 3Unknown
- Start
- Jun 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bendamustine in multiple myeloma (MM). Status: unknown.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT05006469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05006469.